Concepedia
Statistics
Publications
11
Citations
2.4K
H-Index
Active since
1988
Affiliations
The University of Melbourne(Current)
Heidelberg Repatriation Hospital
Baker Heart and Diabetes Institute
Merck & Co., Inc., Rahway, NJ, USA (United States)
Tel Aviv University
M. E. Cooper is an author at The University of Melbourne specializing in medicine, renal disease, and renal pathophysiology.
Publications per year
1988–2013
Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study
C. E. Mogensen, Steen Neldam, I. Tikkanen et al. · BMJ · 2000 · 1K citations · Full text
Pharmacy, Internal Medicine, Pharmacotherapy +17
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
B. M. Brenner, M. E. Cooper, Dick de Zeeuw · ACC Current Journal Review · 2002 · 511 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +17
Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension
M. E. Cooper, Geoffrey Boner, Zemin Cao et al. · Diabetologia · 2001 · 247 citations · Full text
Medicine, Nephrology, Physiology +11
Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition.
Richard E. Gilbert, Angela Cox, Linlin Wu et al. · Diabetes · 1998 · 203 citations
Medicine, Nephrology, Pathology +17
The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulation
M. E. Cooper, Vicki Thallas, Josephine M. Forbes et al. · Diabetologia · 2000 · 103 citations · Full text
Medicine, Biochemistry, Pharmacology +6
1–5 of 11